Publications by authors named "Marta Polo"

Claim this Profile
Q
Quizartinib for Newly Diagnosed -Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, Jesús Lorenzo Algarra Algarra, Carmen Botella, Marta Polo

J Clin Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Quizartinib for Newly Diagnosed -Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
Pau Montesinos, Rebeca Rodríguez-Veiga, Juan Miguel Bergua, Jesús Lorenzo Algarra Algarra, Carmen Botella, Marta Polo

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Jorge Labrador, David Martínez-Cuadrón, Blanca Boluda, Josefina Serrano, Cristina Gil, Marta Polo, Susana Vives-Polo

Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study.
Luciana Del Campo Guerola, Ana Andrea García Sacristán, Antonio Portolés, Maricruz Jasso, Teresa Guerra-Galán, Marta Polo

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study).
Carlos Vallejo, Ana Rosell, Blanca Xicoy, Carmen García, Carmen Albo, Marta Polo

Ann Hematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Marta Sobas, Wanda Knopinska-Posluszny, Beata Piątkowska-Jakubas, Flor García-Álvarez, María Elena Amutio Díez, Marta Polo

Ann Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression.
Juliana Ochoa-Grullón, Kissy Guevara-Hoyer, Cristina Pérez López, Rebeca Pérez de Diego, Ascensión Peña Cortijo, Marta Polo

Biomedicines· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory -ITD Mutation-Positive Acute Myeloid Leukemia.
David Martínez-Cuadrón, Josefina Serrano, José Mariz, Cristina Gil, Mar Tormo, Marta Polo

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
Carlos Vallejo, Pau Montesinos, Marta Polo, Beatriz Cuevas, Marta Morado

Ann Hematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
José María Aguado, Lourdes Vázquez, Mario Fernández-Ruiz, Teresa Villaescusa, Isabel Ruiz-Camps, Marta Polo

Clin Infect Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study.
Alba M Redondo, Helena Pomares, María J Vidal, María J Pascual, Belén Quereda, Marta Polo

Br J Haematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
María-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, Norma Gutiérrez, Ana-Isabel Teruel, Marta Polo

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular characterization of two new mutations of α° thalassemia in two Spanish families (mutation --(ED) and --(GP))].
Ana Villegas, Paloma Ropero, Eduardo Anguita, Aurora Hernández, Marta Polo

Med Clin (Barc)· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hemoglobin Stanleyville II [alpha78(EF7)Asn --> Lys]. First case described in Spain].
Fernando Ataúlfo González, Paloma Ropero, Silvia de la Iglesia, Marta Polo, Celina Benavente

Med Clin (Barc)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of the HFE gene mutations in a cohort of non-Spanish origin neonates in Madrid.
Paloma Ropero, Leopoldo Llorente, Fernando A González, Olga Briceño, Marta Mateo, Marta Polo

Ann Hematol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hb La Coruña [beta38(C4)Thr-->Ile]: a new hemoglobin variant leading to familial polycythemia.
Paloma Ropero, Carlos Fernández-Lago, Ana Villegas, Marta Polo, Marta Mateo

Hemoglobin· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First Spanish case of thalassemia major due to a compound heterozygosity for the IVS-II-848 (C --> A) and codon 39 (C --> T) mutations of the beta-globin gene.
Paloma Ropero, Ana Villegas, Juan Muñoz, Olga Briceño, Asunción Mora, Marta Polo

Hemoglobin· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in a cohort of 1,000 neonates in Madrid (Spain).
Paloma Ropero, Olga Briceño, Marta Mateo, Marta Polo, Asunción Mora

Ann Hematol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The first case of Hb E-Saskatoon associated with Hb Lepore-Baltimore found in Spain.
Paloma Ropero, Maria José Murga, Fernando A González, Marta Polo, Celina Benavente

Hemoglobin· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel mutation of the alpha2-globin causing alpha(+)-thalassemia: Hb Plasencia [alpha125(H8)Leu--Arg (alpha2).
Guillermo Martin, Ana Villegas, Fernando Ataulfo González, Paloma Ropero, Ricardo Hojas, Marta Polo

Hemoglobin· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Association of hemoglobinopathy and alpha thalassemia. Study of 45 patients].
Fernando Ataulfo González, Cristina Blázquez, Paloma Ropero, Olga Briceño, Concha Alaez, Marta Polo

Med Clin (Barc)· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis